New Delhi, July 30 (IANS) The Brain & Behavior Research Foundation (BBRF) has announced the recipients of the 2024 Klerman and Freedman Prizes, recognising outstanding clinical and basic research in mental illness. These prestigious awards honour the work of scientists supported by the Foundation’s Young Investigator Grants Program.
The 2024 Klerman and Freedman prize winners are being recognised for their significant findings related to suicide prevention, PTSD, substance-use disorders, autism, brain biology, and therapeutic drug development,” said Dr Jeffrey Borenstein, President and CEO of the BBRF. He highlighted that their work advances diagnostic tools, identifies effective treatments, and aids in the prevention of mental illness.
The prize winners were selected by the BBRF Scientific Council, comprising 192 leading mental health researchers. Since 1987, the Foundation has awarded over $450 million to more than 5,400 scientists globally. The awards are named after Gerald Klerman, MD, and Daniel Freedman, MD — legendary figures in neuropsychiatry.
Juliet Beni Edgcomb, MD, PhD, University of California, Los Angeles, has been selected for the 2024 Klerman Prize for Exceptional Clinical Research.
Dr Edgcomb is developing methodologies to identify children and adolescents with suicide-related symptoms from electronic health record (EHR) data. Her research aims to establish predictive variables to better recognise suicide-related phenotypes, potentially improving early intervention strategies.
Christina K. Kim, PhD, University of California, is the recipient of the 2024 Freedman Prize for Exceptional Basic Research.
Dr Kim’s work focuses on new methods to record and alter neuronal activity, specifically targeting neurons and molecular biomarkers affected by therapeutic drugs for depression and anxiety. This research could lead to the development of more specific and effective treatments with fewer side effects.
Elizabeth V. Goldfarb, PhD, Yale University, has been chosen for the 2024 Klerman Prize Honorable Mention.
Dr Goldfarb’s lab explores how stress influences memory and subsequent behaviours. Her research integrates cognitive neuroscience and neuroimaging to identify memory markers that could inform therapeutic interventions.
Erin Gibson, PhD, Stanford University, has been selected for the 2024 Freedman Prize Honorable Mention.
Dr Gibson studies the circadian system’s role in neuroendocrine and immune regulation, focusing on the impact of glial cells on neural circuits and their connection to disorders such as autism and Alzheimer’s disease.
Hugo A. Tejeda, PhD, National Institute of Mental Health, is the recipient of the 2024 Freedman Prize Honorable Mention.
Dr Tejeda investigates neuromodulation in limbic neural circuits, examining the role of neuropeptides and dopamine in threat appraisal and motivation, with implications for understanding psychiatric disorders.
–IANS
ts/uk
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
